Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001379344-25-000004
Filing Date
2025-12-08
Accepted
2025-12-08 21:45:06
Documents
1
Period of Report
2025-12-05

Document Format Files

Seq Description Document Type Size
1 form4-12082025_091203.html 4  
1 form4-12082025_091203.xml 4 5710
  Complete submission text file 0001379344-25-000004.txt   7257
Mailing Address C/O ADVERUM BIOTECHNOLOGIES, INC. 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address
Fischer Laurent (Reporting) CIK: 0001379344 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36579 | Film No.: 251557464

Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Issuer) CIK: 0001501756 (see all company filings)

EIN.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)